Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07165327 · ClinicalTrials.gov registry record · NA
Injection Ports vs Single-Use Needles for Insulin in Pregnancy: Effects on Adherence and Satisfaction
A NA study, sponsored by University of Texas at Austin.
- Not yet
- Registry status
- NA
- Development phase
- 44
- Enrollment target
NCT07165327: Clinical Trial NA study, sponsored by University of Texas at Austin.
NCT07165327 is a NA study that has not yet begun recruiting, run by University of Texas at Austin. The registered enrollment target is 44 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07165327, a NA study, has not yet begun recruiting, sponsored by University of Texas at Austin.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 44 participants
- Enrollment target
Study Summary
This study wants to find out if using an injection port to give insulin during pregnancy helps people take their insulin more regularly and feel better about their care. When someone has diabetes during pregnancy, it's very important to keep their blood sugar levels in a healthy range. This usually means checking blood sugar often and giving insulin through shots. But giving many shots each day can be hard and uncomfortable. An injection port is a small device placed on the skin that lets patients give insulin through the same spot without poking themselves each time. This may make taking insulin easier and less painful. Feeling comfortable with how insulin is given may help people stick to their treatment plan and have better health during pregnancy. Injection ports have already helped other patients, including pregnant people who needed other medications, but they haven't been studied for insulin use during pregnancy. This study will look at how pregnant patients with diabetes feel about using injection ports for insulin.
Primary Outcome
Patients' compliance with their insulin administration during each arm will be assessed by determining the total number of insulin doses that were missed.
Interventions
- DEVICE Injection Port for Insulin Administration
- DEVICE Single-Use Insulin Needles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2025-10 |
| Est. Completion | 2026-10 |
| Phase | NA |
What is known before NCT07165327 opens enrollment
NCT07165327 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 44 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 2 interventions - of which Injection Port for Insulin Administration is the first listed.
NCT07165327 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07165327 about?
NCT07165327 is a clinical study titled "Injection Ports vs Single-Use Needles for Insulin in Pregnancy: Effects on Adherence and Satisfaction". This study wants to find out if using an injection port to give insulin during pregnancy helps people take their insulin more regularly and feel better about their care. When someone has diabetes during pregnancy, it's very important to keep their blood sugar levels in a healthy range. This usually...
What is the current status of trial NCT07165327?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 44 participants. The study started on 2025-10. Estimated completion is 2026-10.
What interventions are being tested in trial NCT07165327?
The interventions under investigation include: Injection Port for Insulin Administration (DEVICE), Single-Use Insulin Needles (DEVICE).
Who is sponsoring clinical trial NCT07165327?
This trial is sponsored by University of Texas at Austin, which has 257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07165327's enrollment target sits among peer trials
44 1423rd of 2000 higher than 566 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02323945 · 44 participants · NA
Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury
- NCT03093909 · 44 participants · Phase 1
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
- NCT03104491 · 44 participants · Phase 1
Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
- NCT03781765 · 44 participants · Phase 4
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia